“I have had the pleasure to work with Chrysanthi for the last few years on several innovation topics. Her deep subject knowledge in data science and IT consistently impress me. When you pair that with her passion to innovate and to challenge the status quo, there is no question why the projects are so successful. Chrysanthi is also wonderful at leveraging past experiences in other industries to look at topics differently and bring unexpected ideas and value. She has the ability to look at both the big picture and see how everything comes together, as well as dive into the details and find the story they tell. Chrysanthi is seen as a "go-to" resource when looking to the future and how Bayer will utilize the data we have as well as the new types of data now available in clinical trials. I have no hesitation in recommending her. ”
Chrysanthi Dori, MS, MBA
Iselin, New Jersey, United States
2K followers
500+ connections
About
With more than 20 years of experience as an Executive Technology Leader, I have a proven…
Activity
-
It will take until 2158 to achieve full gender parity at the current rate of progress, according to the World Economic Forum. To close the gap, we…
It will take until 2158 to achieve full gender parity at the current rate of progress, according to the World Economic Forum. To close the gap, we…
Liked by Chrysanthi Dori, MS, MBA
-
💜 Celebrating Strength, Innovation & Empowerment – Women’s Day 2025! ✨ (ParadigmIT, ParadigmIT Cybersecurity, Pathsetter AI) On March 6th, 2025, we…
💜 Celebrating Strength, Innovation & Empowerment – Women’s Day 2025! ✨ (ParadigmIT, ParadigmIT Cybersecurity, Pathsetter AI) On March 6th, 2025, we…
Liked by Chrysanthi Dori, MS, MBA
-
The afternoon sessions at Medidata Solutions’ Hyderabad Innovation Day are jam packed, especially the live demo sessions! Thanks to our subject…
The afternoon sessions at Medidata Solutions’ Hyderabad Innovation Day are jam packed, especially the live demo sessions! Thanks to our subject…
Liked by Chrysanthi Dori, MS, MBA
Experience
Education
-
Rutgers Business School in Collaboration with Columbia University
-
Activities and Societies: Member of Beta Gamma Sigma honor Society
After working for years, I went back to school in Rutgers University and Columbia University, where I completed my Executive MBA in Finance with honors. My exams in Macroeconomics and Microeconomics are still distributed to Exec MBA students as examples.
-
-
Activities and Societies: Member of Beta Gamma Sigma honor Society
I did my final MS project in Cryptography based on RSA Algorithms. I had a full assistantship where I worked one year in Network Systems and the next as a teaching assistant for Programming Languages (undergrad CS students) and undergrad Math.
-
-
Activities and Societies: member of Golden Key Society, Dean’s list all semesters
I am a US Citizen, born in Greece. I attended the National Technical University of Athens In Greece, Civil Engineering. All our books were translated from the University of California-Berkeley. NTUA has the same level of respect and difficulty in the country as MIT. The National Exams in the country are very tough, difficult to get in and very competitive. I took all the advanced Math classes there. I transferred to SUNY Albany with a full scholarship and earned my BS with magna cum laude.
Licenses & Certifications
Volunteer Experience
-
Board Member
Healthcare Innovation & Technology Lab(HITLAB) - Breakthrough Alliance
- Present 2 years 1 month
Science and Technology
Publications
-
Real-Life Multimarker Monitoring in Patients with Heart Failure: Continuous Remote Monitoring of Mobility and Patient-Reported Outcomes as Digital End Points in Future Heart-Failure Trials
Digital Biomarkers
Aims: Heart failure (HF) affects approximately 26 million people worldwide. With an aging global population, innovative approaches to HF evaluation and management are needed to cope with the worsening HF epidemic. The aim of the Real-Life Multimarker Monitoring in Patients with Heart Failure (REALIsM-HF) study (NCT03507439) is to evaluate a composite instrument comprising remote, real-time, activity-monitoring devices combined with daily electronic patient-reported outcome (ePRO) items in…
Aims: Heart failure (HF) affects approximately 26 million people worldwide. With an aging global population, innovative approaches to HF evaluation and management are needed to cope with the worsening HF epidemic. The aim of the Real-Life Multimarker Monitoring in Patients with Heart Failure (REALIsM-HF) study (NCT03507439) is to evaluate a composite instrument comprising remote, real-time, activity-monitoring devices combined with daily electronic patient-reported outcome (ePRO) items in patients who have been hospitalized for HF and are undergoing standard HF assessment (e.g., 6-min walking distance [6MWD], blood biomarkers, Kansas City Cardiomyopathy Questionnaire [KCCQ], and echocardiography)
Other authors -
Patents
-
TestMaster Modeling Bell Labs
Issued US
Other inventors -
Projects
-
Leading Direct Subject Data Acquisition on Clinical Trials in Different Therapeutic Areas
-
Digital Trials
1. Continue to endorse a model that encourages, prototypes and fosters new process ideas/new technology solutions
• Identify partnerships /vendor relationships to define innovative solutions for our business partners.
• Engage in all discussions with different technology vendors and have a deep technical dive by emerging and asking the relevant questions.
Operational
2. Digital Trial Studies: Establish data flow and process governance
Strategic…Digital Trials
1. Continue to endorse a model that encourages, prototypes and fosters new process ideas/new technology solutions
• Identify partnerships /vendor relationships to define innovative solutions for our business partners.
• Engage in all discussions with different technology vendors and have a deep technical dive by emerging and asking the relevant questions.
Operational
2. Digital Trial Studies: Establish data flow and process governance
Strategic Initiatives regarding the Digital Technologies
3. Test Diffusion of Mobile apps and sensors in Clinical Trials
4. Build collaboration network with Business Services, Clinical Sciences and Medical Affairs to ensure an optimized /flexible platform for the use of digital acquisition technologies
5. Explore sensors providing Multimarker monitoring including physical activity under real-life conditions
6. Identify potential new endpoints trials by exploring clinically relevant
changes over time and correlations/associations with conventional endpoints such as biomarkers and clinical events.
7. Address the challenges and feasibility of implementing device based measurements under real-life conditions.
8. Look at items generated from patient experiences (Mobile Apps with questionnaires) in combination with sensors that would capture dimensions of exercise and can be used as patient-centric approach in clinical studies.
Long-Term Outcomes
9. Engage in Digital solutions that help drive adherence to treatment and outcomes that payers and governments seek
10. Generate the data that pharma companies need to demonstrate their drugs' superior efficacy
11. Use data to drive superior insight and decision making.
12. Transform business processes to provide real-time responsiveness.
Languages
-
English
-
-
French
-
-
Greek
-
Recommendations received
5 people have recommended Chrysanthi
Join now to viewMore activity by Chrysanthi
-
Looking forward to an engaging exchange with colleagues from the industry
Looking forward to an engaging exchange with colleagues from the industry
Liked by Chrysanthi Dori, MS, MBA
-
💡Innovation in Action: A Deep Dive with Medidata! Last week was nothing short of inspiring as we got an exclusive peek into the future of Clinical…
💡Innovation in Action: A Deep Dive with Medidata! Last week was nothing short of inspiring as we got an exclusive peek into the future of Clinical…
Liked by Chrysanthi Dori, MS, MBA
-
Launch Day is here! 🎉 I’m beyond excited to officially introduce Braving the Workplace: Belonging at the Breaking Point to the world! Pick up a copy…
Launch Day is here! 🎉 I’m beyond excited to officially introduce Braving the Workplace: Belonging at the Breaking Point to the world! Pick up a copy…
Liked by Chrysanthi Dori, MS, MBA
-
This International Women’s Day (IWD), we are joining the call to #AccelerateAction for gender equality. At Medidata Solutions, we are not just doing…
This International Women’s Day (IWD), we are joining the call to #AccelerateAction for gender equality. At Medidata Solutions, we are not just doing…
Liked by Chrysanthi Dori, MS, MBA
-
Look forward to discussing cutting-edge advancements in clinical data, AI-driven insights, and the future of collaboration in life sciences. Let’s…
Look forward to discussing cutting-edge advancements in clinical data, AI-driven insights, and the future of collaboration in life sciences. Let’s…
Shared by Chrysanthi Dori, MS, MBA
-
🆕 A Big Update is Here | Breakthrough Alliance Europe Conference 2025 We are thrilled to introduce Chrysanthi Dori, MS, MBA, Vice President…
🆕 A Big Update is Here | Breakthrough Alliance Europe Conference 2025 We are thrilled to introduce Chrysanthi Dori, MS, MBA, Vice President…
Liked by Chrysanthi Dori, MS, MBA
-
This International Women’s Day, we celebrate the women who shape the ACDM and inspire our work...... On this day, we proudly recognise their…
This International Women’s Day, we celebrate the women who shape the ACDM and inspire our work...... On this day, we proudly recognise their…
Liked by Chrysanthi Dori, MS, MBA
-
Celebrating International Women's Day! #IWD25 serves as a powerful global moment to celebrate progress, raise awareness of persistent inequalities,…
Celebrating International Women's Day! #IWD25 serves as a powerful global moment to celebrate progress, raise awareness of persistent inequalities,…
Liked by Chrysanthi Dori, MS, MBA
-
🌍 As we celebrate International Women's Day today, it’s essential to engage in vital conversations about women’s health and its impact on society as…
🌍 As we celebrate International Women's Day today, it’s essential to engage in vital conversations about women’s health and its impact on society as…
Liked by Chrysanthi Dori, MS, MBA
-
🚀 Hyderabad Innovation Day 2025 – Driving Transformation in Clinical Trials! (ParadigmIT,ParadigmIT Cybersecurity,Pathsetter AI). On February…
🚀 Hyderabad Innovation Day 2025 – Driving Transformation in Clinical Trials! (ParadigmIT,ParadigmIT Cybersecurity,Pathsetter AI). On February…
Liked by Chrysanthi Dori, MS, MBA
-
🌟I am beyond proud of my mom who retired today after over 30 years of service. 🌟 I am the proud daughter of a single parent and all that I am, I…
🌟I am beyond proud of my mom who retired today after over 30 years of service. 🌟 I am the proud daughter of a single parent and all that I am, I…
Liked by Chrysanthi Dori, MS, MBA
Other similar profiles
Explore collaborative articles
We’re unlocking community knowledge in a new way. Experts add insights directly into each article, started with the help of AI.
Explore More